(RTTNews) - 60 Degrees Pharmaceuticals, Inc. (SXTP), Wednesday announced encouraging findings from its trial of relapsing babesiosis in immunosuppressed patients, reporting that the first patient, who ...

Study intended to confirm the high cure rate for tafenoquine in immunosuppressed patients with relapsing babesiosis, as reported by Yale in a 2024 publication WASHINGTON, Oct. 15, 2025 (GLOBE NEWSWIRE ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Showers and 60-degree temperatures are expected at the beginning of the week in the Sacramento Region. Longevity expert: The healthiest, longest-living people eat these 6 foods in the ...

The information is based on a press release statement and the company’s SEC filing. In other recent news, 60 Degrees Pharmaceuticals , Inc. announced the closing of a public offering that raised $5 ...

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP), currently trading at $1.56 and showing significant volatility in recent months, announced the results of its 2025 Annual Stockholders Meeting, held ...

In an exclusive interview, Dr. Oren Hershkovitz, Chief Executive Officer of Enlivex Therapeutics, will appear on the RedChip Small Stocks Big Money ™ show on Bloomberg TV to discuss the company’s ...

At the end of September, cold air at high altitudes above Antarctica had soared to more than 60 degrees above normal. It is a phenomenon known as "sudden stratospheric warming," and even though they ...

Formula One's multimillionaire drivers will wear protective ice vests in Singapore this weekend during the first Grand Prix declared a 'heat hazard'. The night-time event saps weight and energy from ...

Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. We recently looked at the golf clubs that cost amateurs the most strokes ...